Showing items 1 - 4 of 4

Your selections:

Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance

- Staudt, Dilana, Murray, Heather C., McLachlan, Tabitha, Alvaro, Frank, Enjeti, Anoop K., Verrills, Nicole M., Dun, Matthew D.

Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios

- Saglio, Giuseppe, le Coutre, Philipp, Cortes, Jorge, Mayer, Jiří, Rowlings, Philip, Mahon, François-Xavier, Kroog, Glenn, Gooden, Kyna, Subar, Milayna, Shah, Neil P.

How 'optimal' are optimal sampling times for tyrosine kinase inhibitors in cancer? Practical considerations

- Ward, Michael B., Reuter, Stephanie E., Martin, Jennifer H.

Parallel solution-phase synthesis of targeted tyrphostin libraries with anticancer activity

- Hill, Timothy Adrian, Sakoff, J. A., Robinson, P. J., McCluskey, Adam

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit